# SWIFT - SWIss Factor XIII Trial in PPH

> **NCT06481995** · PHASE4 · RECRUITING · sponsor: **Christian Haslinger** · enrollment: 988 (estimated)

## Conditions studied

- Postpartum Hemorrhage
- Coagulation Disorder
- Coagulation Factor Deficiency
- Hemorrhage
- Postpartum Complication

## Interventions

- **DRUG:** Fibrogammin

## Key facts

- **NCT ID:** NCT06481995
- **Lead sponsor:** Christian Haslinger
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 988 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481995, "SWIFT - SWIss Factor XIII Trial in PPH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06481995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*